Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Sep 9, 2015

Total Value: $309M (100.0% shares, 0.0% debt)

Holdings (69)

— ALLERGAN PLC 4.4%
Value $13.66M Shares 45,000 Share Price $303.47 Est. Cost/Share $303.47 Unrealized @ Report Date —
— FLAMEL TECHNOLOGIES SA 3.9%
Value $12.18M Shares 575,000 Share Price $21.19 Est. Cost/Share $19.78 Unrealized @ Report Date —
BIIB BIOGEN INC 3.9%
Value $12.12M Shares 30,000 Share Price $403.93 Est. Cost/Share $401.33 Unrealized @ Report Date 0.0%
— NUVASIVE INC 3.6%
Value $11.13M Shares 235,000 Share Price $47.38 Est. Cost/Share $44.27 Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 3.5%
Value $10.79M Shares 90,000 Share Price $119.87 Est. Cost/Share $98.18 Unrealized @ Report Date +21.7%
— FIVE PRIME THERAPEUTICS INC 3.4%
Value $10.56M Shares 425,000 Share Price $24.84 Est. Cost/Share $24.37 Unrealized @ Report Date —
ISRG INTUITIVE SURGICAL INC 3.1%
Value $9.69M Shares 20,000 Share Price $484.50 * Est. Cost/Share $55.94 Unrealized @ Report Date 0.0%
— ENDO INTL PLC 3.1%
Value $9.558M Shares 120,000 Share Price $79.65 Est. Cost/Share $79.65 Unrealized @ Report Date —
— GW PHARMACEUTICALS PLC 3.0%
Value $9.213M Shares 75,000 Share Price $122.84 Est. Cost/Share $103.82 Unrealized @ Report Date —
— ALEXION PHARMACEUTICALS INC 2.9%
Value $9.039M Shares 50,000 Share Price $180.78 Est. Cost/Share $180.78 Unrealized @ Report Date —
— PORTOLA PHARMACEUTICALS INC 2.5%
Value $7.744M Shares 170,000 Share Price $45.55 Est. Cost/Share $27.98 Unrealized @ Report Date —
VRTX VERTEX PHARMACEUTICALS INC 2.4%
Value $7.409M Shares 60,000 Share Price $123.48 * Est. Cost/Share $125.98 Unrealized @ Report Date 0.0%
— HORIZON PHARMA PLC 2.3%
Value $6.948M Shares 200,000 Share Price $34.74 Est. Cost/Share $34.74 Unrealized @ Report Date —
— GENMARK DIAGNOSTICS INC 2.2%
Value $6.795M Shares 750,000 Share Price $9.06 Est. Cost/Share $9.06 Unrealized @ Report Date —
— NANOSTRING TECHNOLOGIES INC 2.0%
Value $6.168M Shares 400,000 Share Price $15.42 Est. Cost/Share $12.91 Unrealized @ Report Date —
ESPR ESPERION THERAPEUTICS INC NE 2.0%
Value $6.132M Shares 75,000 Share Price $81.76 * Est. Cost/Share $97.89 Unrealized @ Report Date 0.0%
— CEPHEID 2.0%
Value $6.115M Shares 100,000 Share Price $61.15 Est. Cost/Share $55.89 Unrealized @ Report Date —
— CIGNA CORPORATION 2.0%
Value $6.075M Shares 37,500 Share Price $162.00 Est. Cost/Share $162.00 Unrealized @ Report Date —
— EPIZYME INC 1.9%
Value $6M Shares 250,000 Share Price $24.00 Est. Cost/Share $21.60 Unrealized @ Report Date —
NBIX NEUROCRINE BIOSCIENCES INC 1.9%
Value $5.851M Shares 122,500 Share Price $47.76 * Est. Cost/Share $42.40 Unrealized @ Report Date 0.0%
FOLD AMICUS THERAPEUTICS INC 1.7%
Value $5.306M Shares 375,000 Share Price $14.15 * Est. Cost/Share $7.47 Unrealized @ Report Date +61.0%
— ATARA BIOTHERAPEUTICS INC 1.7%
Value $5.276M Shares 100,000 Share Price $52.76 Est. Cost/Share $52.76 Unrealized @ Report Date —
DXCM DEXCOM INC 1.7%
Value $5.199M Shares 65,000 Share Price $79.98 * Est. Cost/Share $17.56 Unrealized @ Report Date 0.0%
— AETNA INC NEW 1.7%
Value $5.098M Shares 40,000 Share Price $127.45 Est. Cost/Share $127.45 Unrealized @ Report Date —
— ANACOR PHARMACEUTICALS INC 1.6%
Value $5.033M Shares 65,000 Share Price $77.43 Est. Cost/Share $77.43 Unrealized @ Report Date —
QURE UNIQURE NV 1.6%
Value $4.995M Shares 185,000 Share Price $27.00 * Est. Cost/Share $28.48 Unrealized @ Report Date 0.0%
— ENDOCHOICE HLDGS INC 1.6%
Value $4.905M Shares 300,000 Share Price $16.35 Est. Cost/Share $16.35 Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 1.6%
Value $4.813M Shares 100,000 Share Price $48.13 * Est. Cost/Share $45.25 Unrealized @ Report Date +28.9%
CLLS CELLECTIS S A 1.5%
Value $4.51M Shares 125,000 Share Price $36.08 Est. Cost/Share $36.08 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 1.4%
Value $4.442M Shares 350,000 Share Price $12.69 * Est. Cost/Share $10.78 Unrealized @ Report Date 0.0%
— ZELTIQ AESTHETICS INC 1.4%
Value $4.421M Shares 150,000 Share Price $29.47 Est. Cost/Share $25.00 Unrealized @ Report Date —
— CYNAPSUS THERAPEUTICS INC 1.4%
Value $4.279M Shares 262,696 Share Price $16.29 Est. Cost/Share $16.29 Unrealized @ Report Date —
IRWD IRONWOOD PHARMACEUTICALS INC 1.4%
Value $4.221M Shares 350,000 Share Price $12.06 * Est. Cost/Share $11.62 Unrealized @ Report Date 0.0%
— SAGE THERAPEUTICS INC 1.4%
Value $4.198M Shares 57,500 Share Price $73.01 Est. Cost/Share $50.23 Unrealized @ Report Date —
— VITAE PHARMACEUTICALS INC 1.3%
Value $4.164M Shares 289,200 Share Price $14.40 Est. Cost/Share $11.71 Unrealized @ Report Date —
— WRIGHT MED GROUP INC 1.3%
Value $3.939M Shares 150,000 Share Price $26.26 Est. Cost/Share $26.87 Unrealized @ Report Date —
— ALCOBRA LTD 1.3%
Value $3.924M Shares 600,000 Share Price $6.54 Est. Cost/Share $5.63 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 1.2%
Value $3.763M Shares 1,250,000 Share Price $3.01 Est. Cost/Share $2.45 Unrealized @ Report Date —
— GENOCEA BIOSCIENCES INC 1.2%
Value $3.707M Shares 270,000 Share Price $13.73 Est. Cost/Share $11.86 Unrealized @ Report Date —
— ASSEMBLY BIOSCIENCES INC 1.1%
Value $3.371M Shares 175,000 Share Price $19.26 Est. Cost/Share $13.08 Unrealized @ Report Date —
ELV ANTHEM INC 1.1%
Value $3.283M Shares 20,000 Share Price $164.15 * Est. Cost/Share $137.52 Unrealized @ Report Date 0.0%
— ROCKWELL MED INC 1.0%
Value $3.224M Shares 200,000 Share Price $16.12 Est. Cost/Share — Unrealized @ Report Date —
— KEMPHARM INC 1.0%
Value $3.215M Shares 175,000 Share Price $18.37 Est. Cost/Share $18.37 Unrealized @ Report Date —
— LION BIOTECHNOLOGIES INC 1.0%
Value $3.21M Shares 350,000 Share Price $9.17 Est. Cost/Share $10.85 Unrealized @ Report Date —
— THERAPEUTICSMD INC 1.0%
Value $3.144M Shares 400,000 Share Price $7.86 Est. Cost/Share $5.07 Unrealized @ Report Date —
— AXOVANT SCIENCES LTD 0.9%
Value $2.751M Shares 135,000 Share Price $20.38 Est. Cost/Share $20.38 Unrealized @ Report Date —
— FOAMIX PHARMACEUTICALS LTD 0.8%
Value $2.563M Shares 250,000 Share Price $10.25 Est. Cost/Share $10.25 Unrealized @ Report Date —
— AVALANCHE BIOTECHNOLOGIES IN 0.8%
Value $2.436M Shares 150,000 Share Price $16.24 Est. Cost/Share $46.08 Unrealized @ Report Date —
— BIODELIVERY SCIENCES INTL IN 0.8%
Value $2.388M Shares 300,000 Share Price $7.96 Est. Cost/Share $7.96 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 0.7%
Value $2.314M Shares 31,700 Share Price $73.00 Est. Cost/Share $50.23 Unrealized @ Report Date —
PBYI PUMA BIOTECHNOLOGY INC 0.7%
Value $2.043M Shares 17,500 Share Price $116.74 * Est. Cost/Share $214.23 Unrealized @ Report Date -15.5%
— TONIX PHARMACEUTICALS HLDG C 0.6%
Value $1.816M Shares 202,500 Share Price $8.97 Est. Cost/Share $8.97 Unrealized @ Report Date —
— RADIUS HEALTH INC 0.5%
Value $1.693M Shares 25,000 Share Price $67.72 Est. Cost/Share $41.16 Unrealized @ Report Date —
— VERSARTIS INC 0.5%
Value $1.522M Shares 100,000 Share Price $15.22 Est. Cost/Share $15.22 Unrealized @ Report Date —
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 0.5%
Value $1.409M Shares 76,850 Share Price $18.33 Est. Cost/Share $18.33 Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 0.4%
Value $1.127M Shares 63,739 Share Price $17.68 Est. Cost/Share $17.68 Unrealized @ Report Date —
— UNILIFE CORP NEW 0.3%
Value $968K Shares 450,000 Share Price $2.15 Est. Cost/Share $4.01 Unrealized @ Report Date —
VCYT VERACYTE INC 0.3%
Value $873K Shares 78,386 Share Price $11.14 * Est. Cost/Share $9.84 Unrealized @ Report Date 0.0%
— BIODELIVERY SCIENCES INTL IN 0.3%
Value $845K Shares 106,200 Share Price $7.96 Est. Cost/Share $7.96 Unrealized @ Report Date —
— NIVALIS THERAPEUTICS INC 0.2%
Value $758K Shares 50,000 Share Price $15.16 Est. Cost/Share $15.16 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 0.2%
Value $672K Shares 45,000 Share Price $14.93 * Est. Cost/Share $11.37 Unrealized @ Report Date 0.0%
— KINDRED BIOSCIENCES INC 0.2%
Value $638K Shares 93,500 Share Price $6.82 Est. Cost/Share $7.14 Unrealized @ Report Date —
— BIOLASE INC 0.2%
Value $522K Shares 300,000 Share Price $1.74 Est. Cost/Share $2.41 Unrealized @ Report Date —
— XOMA CORP DEL 0.2%
Value $485K Shares 125,000 Share Price $3.88 Est. Cost/Share $3.74 Unrealized @ Report Date —
— OCERA THERAPEUTICS INC 0.2%
Value $475K Shares 125,000 Share Price $3.80 Est. Cost/Share $10.04 Unrealized @ Report Date —
GKOS GLAUKOS CORP 0.1%
Value $435K Shares 15,000 Share Price $29.00 Est. Cost/Share $29.05 Unrealized @ Report Date 0.0%
XENE XENON PHARMACEUTICALS INC 0.1%
Value $432K Shares 37,500 Share Price $11.52 * Est. Cost/Share $13.82 Unrealized @ Report Date 0.0%
— NEOTHETICS INC 0.1%
Value $387K Shares 43,000 Share Price $9.00 Est. Cost/Share $9.00 Unrealized @ Report Date —
— AVALANCHE BIOTECHNOLOGIES IN 0.1%
Value $244K Shares 15,000 Share Price $16.27 Est. Cost/Share $46.08 Unrealized @ Report Date —